Press release
Global Ophthalmol Drugs Market Top Leading Players with Strategies and Forecast 2022-2028
The global Ophthalmol drugs market is anticipated to grow at a significant CAGR of 5.5% during the forecast period (2022-2028). The global Ophthalmol drugs market is growing due to the rising prevalence of eye-related disorders, rising research and development activities related to the development of novel drugs, and increasing focus on developing combination therapies globally. According to a survey conducted by World Health Organization in October 2021, around 2.2 billion people have distance or near vision impairment. Out of these 2.2 billion vision impairment patients, glaucoma accounts for 7 million patients, and cataract accounts for 94 million patients globally. The rising prevalence of eye diseases is increasing the demand for Ophthalmol drugs, globally. Additionally, geriatric and diabetic patients are mostly diagnosed with glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Thus, the rising population of geriatric and diabetic patients is also boosting the demand for Ophthalmol drugs.The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and launches, to stay competitive in the market. For instance-
• In January 2022, Sun Pharmaceutical Industries Ltd. announced its launch of a dry eye treatment product in Canada.
• In December 2021, IACTA Pharmaceuticals, Inc. announced their strategic collaboration with TALLC Inc. to employ novel drug delivery technology in new ophthalmic therapeutic.
• In October 2021, US Food and Drug Administration approved VUITY 1.25%, the first and only eye drop to treat presbyopia commonly known as the age-related blurry near vision in adults. This drug was launched by AbbVie Inc.
• In August 2021, DelSiTech Ltd. announced its exclusive collaboration with VISUS THERAPEUTICS for the development of long-acting therapies in ophthalmology.
• In September 2020, Micro Labs USA, Inc. announced the launch of two products Dorzolamide 2% and Dorzolamide-Timolol 22.3-6.8 mg/mL for the treatment of glaucoma in the US market.
• In June 2020, Otsuka Pharmaceutical Co., Ltd. and Senju Pharmaceutical Co., Ltd. announced their collaboration for the launch of the new drug AILAMIDE in Japan for the treatment of glaucoma and ocular hypertension.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Ophthalmol Drugs Market at:
https://orionmarketreports.com/request-sample/?id=101441&submit=Request+Sample%0D%0A
Market Coverage
• The market number available for - 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Drug Class
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Bausch & Lomb Inc., Novartis AG, Pfizer Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd., and Johnson & Johnson, Inc., among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
A full report of Global Ophthalmol Drugs Market is available at:
https://orionmarketreports.com/global-ophthalmol-drugs-market/101441/
Global Ophthalmol Drugs Market Report by Segment
By Type
• Prescription Drugs
• Over-the-counter-Drugs
By Drug Class
• Anti-Glaucoma Drug
• Dry Eye Drug
• Ophthalmic Anti-allergy/Inflammatory
• Retinal Drug
• Anti-infective Drugs
• Other Drugs
Global Ophthalmol Drugs Market Report by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Ophthalmol Drugs Market Top Leading Players with Strategies and Forecast 2022-2028 here
News-ID: 2608371 • Views: …
More Releases from Orion Market Reports
Sodium Cromoglicate API Market to Expand With Strong Development by 2031
The Sodium Cromoglicate API Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Sodium Cromoglicate API (active pharmaceutical ingredient) is a type of medication used to treat allergic conditions such as hay fever, allergic conjunctivitis, and asthma. It works by stabilizing mast cells and preventing the release of allergic substances that cause symptoms like itching, redness, and swelling.
Sodium Cromoglicate API Market…
Soda Ash and Aluminium Trihydrate (ATH) Market Will Generate Record Revenue by 2 …
The Soda Ash and Aluminium Trihydrate (ATH) Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Soda Ash, also known as sodium carbonate, is a white, odorless powder used in manufacturing glass, detergents, chemicals, and other industrial applications. Aluminium Trihydrate (ATH) is a white, non-toxic powder primarily used as a flame retardant in plastics, rubber, and textiles.
Soda Ash and Aluminium Trihydrate…
Single Crystal Silicon Wafers Market Provides Information on Historical Growth, …
The Single Crystal Silicon Wafers Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Single crystal silicon wafers are thin, disc-shaped substrates made from a single crystal of silicon. They are a fundamental component in the semiconductor industry and serve as the foundation for manufacturing integrated circuits (ICs) and other microelectronic devices.
Single Crystal Silicon Wafers Market research analyzes the entire market,…
Silicone For Personal Care Market Growth Drivers, Developments, Technology And F …
The Silicone For Personal Care Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Silicone for personal care refers to the use of silicone-based ingredients and formulations in various cosmetic and personal care products. Silicone compounds are valued in the personal care industry for their unique properties, including their smooth texture, excellent spreadability, water resistance, film-forming ability, and compatibility with skin…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
